Related Experiment Video
Updated: Jul 23, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Coronavirus disease 2019 and acute cerebrovascular events: a comprehensive overview
Wanzhou Zhang1,2, Li Ling1, Jie Li1
1Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, causing COVID-19, is linked to cerebrovascular events. Potential mechanisms include hypercoagulability and inflammation, with ongoing research into treatments.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiovascular Medicine
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has seen a rise in acute cerebrovascular events.
- Cerebrovascular complications include cerebral infarction, hemorrhage, and venous thrombosis in COVID-19 patients.
Purpose of the Study:
- To explore the mechanisms linking SARS-CoV-2 infection to acute cerebrovascular events.
- To review characteristics and treatment options for COVID-19-related cerebrovascular complications.
Main Methods:
- Literature review and synthesis of existing research on SARS-CoV-2 and cerebrovascular events.
- Analysis of proposed pathophysiological pathways, including hypercoagulability, inflammation, and renin-angiotensin-aldosterone system alterations.
Main Results:
- SARS-CoV-2 infection is associated with increased risk of ischemic and hemorrhagic stroke.
- Hypercoagulable state and excessive inflammation are implicated in COVID-19-related cerebrovascular events.
- Alterations in the ACE-2 pathway may contribute to these complications.
Conclusions:
- Understanding the mechanisms of SARS-CoV-2-induced cerebrovascular events is crucial for patient management.
- Further research is needed to optimize treatment strategies for COVID-19 patients experiencing neurological complications.
Abstract:
Since the Corona Virus Disease 2019 (COVID-19) pandemic, there has been increasing evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with acute cerebrovascular events such as cerebral infarction, cerebral hemorrhage, and cerebral venous thrombosis. Although the mechanism of cerebrovascular complications among COVID-19 patients has not been adequately elucidated, the hypercoagulable state, excessive inflammation and ACE-2-associated alterations in the renin-angiotensin-aldosterone system after SARS-CoV-2 infection probably play an essential role. In this overview, we discuss the possible mechanisms underlying the SARS-CoV-2 infection leading to acute cerebrovascular events and review the characteristics of COVID-19-related acute cerebrovascular events cases and treatment options available worldwide.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Coronary Artery Disease I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

